Brief: Canadian Generics Pharmaceutical Manufacturer Selects Kneat's Saas E-Validation Platform
10/03/2022 14:14
March 10 (Reuters) - Kneat.com Inc KSI.TO :
* CANADIAN GENERICS PHARMACEUTICAL MANUFACTURER SELECTS
KNEAT'S
SAAS E-VALIDATION PLATFORM
Source text for Eikon: ID:nCNWXbkFza
Further company coverage: KSI.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Kneat.com
See all newsBrief: Kneat Shareholders Overwhelmingly Approve Transaction With Thoma Bravo
Ireland's Kneat Q1 revenue rises on digitalization demand
Brief: Kneat Q1 Revenue CAD 18 Million Vs. IBES Estimate CAD 18 Million
Brief: Kneat.Com Confirms Strategic Review Of Alternatives Underway
Canada's Kneat Q4 revenue rises